Explore 3 Stock Ideas & Industry Insights Download Free Report

UFP Technologies Inc

Company price
303.47 USD 3.65 ( 1.22%)
Last update at 2026-11-06T21:00:00Z
VOLUME
103703
Market Cap
2133.73M
P/E
30.04

Momentum Score

…

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
292.60
Low
306.19
High
52 Week Price Range
173.86
Low
338.71
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
299.82
Dividend Yield
-
Revenue TTM
631.64M
Revenue Per Share
81.80
Gross Profit TTM
180.00M
Debt / Equity
0.36
ROE
17.05%
Net Debt
134.18M
ROCE
15.62%
Diluted EPS TTM
9.17

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 82.51M 73.03M 53.90M 52.72M 21.20M
Net income 68.31M 58.98M 44.92M 41.79M 15.89M
Selling general administrative 77.44M 62.22M 49.66M 55.63M 29.48M
Gross profit 170.41M 146.69M 112.22M 90.26M 51.11M
Reconciled depreciation 19.15M 14.71M 11.20M 11.89M 8.41M
Ebit 92.32M 81.09M 57.55M 21.64M 21.22M
Ebitda 115.74M 95.80M 68.95M 33.53M 30.12M
Depreciation and amortization 23.43M 14.71M 11.41M 11.89M 8.90M
Non operating income net other - - - 0.08M 0.07M
Operating income 92.34M 80.90M 57.66M 21.64M 21.22M
Other operating expenses 510.46M 423.52M 342.41M 309.33M 184.69M
Interest expense 9.80M 8.06M 3.65M 2.76M 0.09M
Tax provision 14.20M 14.04M 10.00M 10.93M 5.32M
Interest income - - - - 0.05M
Net interest income -9.80M -8.06M -3.76M -2.76M -0.04M
Non recurring - - - -5.12M 0.42M
Income tax expense 14.20M 14.04M 8.98M 10.93M 5.32M
Total revenue 602.80M 504.42M 400.07M 353.79M 206.32M
Total operating expenses 78.07M 65.80M 54.56M 45.80M 29.48M
Cost of revenue 432.39M 357.73M 287.85M 263.53M 155.21M
Total other income expense net -9.82M -7.87M -3.76M 31.08M -0.01M
Net income from continuing ops 68.31M 58.98M 41.78M 41.79M 15.89M
Net income applicable to common shares - - - 41.79M 15.89M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 665.74M 629.00M 404.14M 377.54M 334.13M
Intangible assets 140.85M 144.25M 64.12M 68.36M 67.58M
Other current assets 5.62M 4.30M 3.43M 3.24M 3.38M
Total liab 241.86M 286.24M 118.05M 140.00M 139.69M
Total stockholder equity 423.88M 342.76M 286.09M 237.54M 194.45M
Deferred long term liab - - - - 7.60M
Other current liab 28.80M 30.41M 22.09M 27.12M 13.61M
Common stock 0.08M 0.08M 0.08M 0.08M 0.07M
Capital stock 0.08M 0.08M 0.08M 0.08M 0.07M
Retained earnings 374.81M 306.50M 247.52M 202.60M 160.81M
Other liab - - - 22.84M 104.98M
Good will 197.40M 189.66M 113.26M 113.03M 107.91M
Other assets 47.65M - - 9.23M 14.75M
Cash 20.30M 13.45M 5.26M 4.45M 11.12M
Total current liabilities 74.86M 76.30M 58.21M 55.76M 34.71M
Current deferred revenue 4.24M 4.67M 6.62M 4.68M 4.25M
Net debt 134.18M 192.58M 40.77M 50.55M 73.24M
Short term debt 17.54M 16.73M 7.22M 4.00M 6.24M
Short long term debt 12.50M 12.50M 4.00M 4.00M 4.00M
Short long term debt total 154.48M 206.03M 46.04M 55.00M 84.36M
Other stockholder equity 45.28M 40.35M 38.23M 35.48M 33.56M
Property plant equipment - - - 58.07M 56.57M
Total current assets 201.00M 194.94M 144.63M 116.35M 87.32M
Long term investments 6.93M 6.81M - - -
Net tangible assets - - - 237.54M 18.96M
Net receivables 88.22M 89.66M 65.75M 55.12M 39.38M
Long term debt 122.95M 176.88M 28.00M 51.00M 71.00M
Inventory 86.86M 87.54M 70.19M 53.54M 33.44M
Accounts payable 24.29M 24.27M 22.29M 19.96M 10.61M
Accumulated other comprehensive income 3.71M -4.17M 0.27M -0.61M -
Common stock total equity - - - 0.08M 0.07M
Retained earnings total equity - - - 202.60M 160.81M
Treasury stock - - - -0.59M -0.59M
Non currrent assets other 10.91M 6.62M 5.79M 20.29M 5.43M
Non current assets total 464.73M 434.05M 259.50M 261.20M 246.81M
Capital lease obligations 19.03M 16.66M 14.04M 13.37M 9.36M
Long term debt total - - - - 71.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -210.16M -10.70M 1.29M -101.46M
Change to liabilities - - - 16.28M -0.33M
Total cashflows from investing activities -27.60M -210.16M -10.49M 1.29M -101.46M
Net borrowings -53.98M 157.30M -23.06M -20.00M 74.84M
Total cash from financing activities -58.16M 152.39M -30.02M -25.89M 74.05M
Change to operating activities - - - 2.91M -1.67M
Net income 68.31M 58.98M 44.92M 41.79M 15.89M
Change in cash 6.85M 8.19M 0.81M -6.67M -13.12M
Begin period cash flow 13.45M 5.26M 4.45M 11.12M 24.23M
End period cash flow 20.30M 13.45M 5.26M 4.45M 11.12M
Total cash from operating activities 91.91M 66.59M 41.33M 17.74M 14.29M
Depreciation 19.15M 14.71M 11.41M 11.89M 8.41M
Other cashflows from investing activities 0.05M -3.03M 0.00M 15.07M -96.06M
Change to inventory 3.90M -4.69M -16.57M -19.61M -4.50M
Change to account receivables 4.79M -2.19M -12.11M -16.86M -9.42M
Sale purchase of stock - -4.95M -2.64M 0.39M 0.16M
Other cashflows from financing activities -4.43M -0.19M -7.70M 37.78M 74.08M
Change to netincome - - - -13.46M 0.62M
Capital expenditures 12.93M 9.66M 10.49M 13.78M 5.39M
Change receivables - - - -16.86M -7.75M
Cash flows other operating - - - -2.28M 1.95M
Cash and cash equivalents changes - - - -6.86M -13.12M
Change in working capital -9.70M -16.34M -24.13M -22.47M -10.63M
Stock based compensation 8.85M 6.84M 4.64M 3.21M 2.43M
Other non cash items 0.18M 1.06M 3.67M -11.96M -0.01M
Free cash flow 78.98M 56.94M 30.84M 3.96M 8.90M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
UFPT
UFP Technologies Inc
3.65
1.22%
303.47 30.04 21.83 3.38 4.66 3.61 19.65
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

UFP Technologies Inc

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

100 Hale Street, Newburyport, MA, United States, 01950-3504

978 352 2200

4846

Name Title Year Born
Mr. R. Jeffrey Bailly Chairman of Directors, Pres & CEO 1962
Mr. Ronald J. Lataille CFO, Sr. VP & Treasurer 1962
Mr. Christopher P. Litterio Esq. Gen. Counsel, Sec. & Sr. VP of HR 1963
Mr. Mitchell Caplan Rock Pres of MedTech 1968
Mr. Steve Cardin VP & COO of MedTech NA
Mr. R. Jeffrey Bailly CEO & Chairman 1962
Mr. Mitchell Caplan Rock President 1968
Mr. Ronald J. Lataille CFO, Senior VP & Treasurer 1962
Mr. Christopher P. Litterio Esq. General Counsel, Secretary & Senior VP of Human Resources 1963
Mr. Steven G. Cardin VP & COO of MedTech NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…